Results 41 to 50 of about 2,661 (133)

Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease

open access: yesInternational Journal of General Medicine, 2021
Yunqi Bao,1 Wei Zhang,1 Dandan Shi,2 Weili Bai,1 Dongdong He,1 Dan Wang1 1Department of Rheumatology, Xi’an Fifth Hospital, Xian, 710000, Shaanxi, People’s Republic of China; 2Department of Radiology, Xi’an Fifth Hospital, Xian, 710000,
Bao Y   +5 more
doaj  

Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis

open access: yesFrontiers in Cell and Developmental Biology, 2021
AimWe aimed to develop and validate a comprehensive nomogram containing pre-treatment plasma HSP90AA1 to predict the risk of breast cancer onset and metastasis.MethodsWe assessed the expression of HSP90s in breast cancer patients using an online database.
Haizhou Liu   +8 more
doaj   +1 more source

Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy

open access: yesCancer Medicine, 2022
To reveal the correlation of dynamic serum tumor markers (STMs) and molecular features of epidermal growth factor receptor‐mutated (EGFR‐mutated) lung cancer during targeted therapy, we retrospectively reviewed 303 lung cancer patients who underwent ...
Zhuxing Chen   +17 more
doaj   +1 more source

CA153等在乳腺癌肺癌及几种疾病中的应用

open access: yesZhongguo shiyan zhenduanxue, 2007
目的探讨血清以及胸水中CA153在乳腺癌及肺部疾病中的临床应用价值。方法采用微粒子酶免疫化学发光分析法对16例乳腺癌患者血清、27例肺癌患者的血清以及其中8例肺癌患者的胸水、122例肺部良性疾病患者的血清及113例正常健康体检者的血清进行CA153、CEA、CA199、CA125水平测定。结果乳腺癌患者血清CA153水平(37.06±75.03 U/ml)为各种疾病中最高;肺癌组4项肿瘤标志物的水平显著高于正常对照组与肺部良性疾病组 ...
胡望平   +8 more
doaj  

血清CA153、BXTM及CEA联合检测对乳腺癌的早期诊断价值比较

open access: yesZhongguo shiyan zhenduanxue, 2020
目的分析血清肿瘤标志物CA153、BXTM与CEA单独及联合检测对乳腺癌的早期诊断价值。方法选择2014年2月-2015年1月来我院诊治的疑似乳腺癌患者286例,均行病理活检,采用酶联免疫法检测血清肿瘤标志物CA153、BXTM与CEA,比较乳腺癌及乳腺良性病变患者各指标差异,分析三指标单独检测及联合检测对乳腺癌的诊断效能。结果 286例患者病理检测确诊为乳腺癌108例,乳腺良性病变178例。乳腺癌患者血清CA153、CEA及BXTM水平均明显高于乳腺良性病变患者 ...
陈琛   +6 more
doaj  

Additional file 2 of Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction

open access: yes, 2022
Additional file 2.
Jia, Li   +6 more
openaire   +1 more source

Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA.

open access: yesChinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2014
MicroRNA-21 (miR-21) has been shown to be a key regulator of carcinogenesis. There were few reports about the comparison of serum miR-21 with conventional tumor markers. This study aimed to explore the diagnostic value of circulating miR-21 as a tumor marker in breast cancer (BC) and compare it with CA153 and carcinoembryonic antigen (CEA).Circulating ...
Jianjian, Gao   +4 more
openaire   +1 more source

Additional file 1 of Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction

open access: yes, 2022
Additional file 1.
Jia, Li   +6 more
openaire   +1 more source

[Expression and significance of CEA and CA153 in pleural fluid of patients with lung cancer].

open access: yesZhongguo fei ai za zhi = Chinese journal of lung cancer, 2011
Finding the cancer cells in pleural fluid of patients with lung can-cer by conventional cytology is always a difficult point. In order to enhance the diagnostic rate of pleural fluid with lung cancer, carcinoembryonic antigen (CEA) and cancer antigen 153 (CA153) were detected in serum and pleural fluid, and their diagnostic values on lung cancer were ...
Dawei, Zou   +4 more
openaire   +1 more source

Changes of serum tumor marker levels and analysis of risk factors in patients with chronic kidney disease

open access: yesLinchuang shenzangbing zazhi, 2020
Objective To investigate whether the expression of serum tumor markers in patients with chronic kidney disease(CKD)has changed,and to analyze the risk factors influencing the changes.Methods The serum tumor markers[including α-fetoprotein(AFP ...
YU Jun-nan   +3 more
doaj  

Home - About - Disclaimer - Privacy